Episode Details

Back to Episodes
Ep. 634 Heart Disease Risk, Lipids, and Imaging |Menopause, Perimenopause, Heart Health

Ep. 634 Heart Disease Risk, Lipids, and Imaging |Menopause, Perimenopause, Heart Health

Published 1 month, 1 week ago
Description

Welcome to this week’s Midlife Minute episode!

Statistically, one in three women will die of heart disease. So, today, we’re answering some of the many questions I received about lipids and heart health. Although I’ve done other lipid-focused Midlife Minutes before, this episode is yet another dedicated to Dr. Tom Dayspring, as I’ve received such a vast number of questions on this particular topic.   

IN THIS EPISODE, YOU WILL LEARN:

  • Why understanding your ApoB and Lp(a) is an essential part of assessing your cardiovascular risk

  • Why treatments for lipid abnormalities should be individualized to fit each specific abnormality 

  • Essential lifestyle measures for supporting overall cardiovascular health

  • How CAC scoring, CT coronary angiography, and Clearly AI-assisted imaging differ, what each test measures, and their limitations 

  • How cardiovascular disease can sometimes present differently in women 

  • Why are premature atrial contractions and premature ventricular contractions often benign when the heart is structurally normal?

  • How the roles of statins, ezetimibe, PCSK9 inhibitors, GLP-1 medications, and emerging RNA therapies differ, and why they should not be considered interchangeable

  • How declining estrogen impacts cardiovascular health

Connect with Cynthia Thurlow  

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us